From ROS-Responsive Nanosystems to Microbiome Modulation: Advanced Drug Delivery Reshaping Inflammatory Bowel Disease and Chronic Inflammatory Diseases
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, serves as a compelling model for advanced drug delivery innovation owing to its well-characterised inflammatory microenvironment and significant unmet clinical need. This semi-systematic review evaluated three converging innovation s...